Arrangement of Financing for TPG’s Acquisition of Vertafore
June 15, 2010
On June 10, 2010, Vertafore, a leading provider of software and services to the insurance industry, announced a definitive merger agreement in which the company will be acquired by investment funds managed by TPG Capital (“TPG”) for a total consideration of $1.4 billion. TPG will purchase the company from Hellman & Friedman and its co-investor JMI Equity. Cravath advised Credit Suisse, BofA Merrill Lynch and Barclays Capital on financing matters in connection with this transaction. The acquisition is expected to close in the third quarter, subject to customary regulatory approvals.
The Cravath team includes partners Michael S. Goldman, James C. Vardell, III and Craig F. Arcella; senior attorney Christopher J. Kelly; associates B.J. Rosen, Rose Stella, Aaron M. Golden and Helen O. Ogbara; and summer associate Eva S. Hibnick.
Related Practices & Industries
People
- Photo
-
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 1995, Duke University
- New York
Education
Admitted In
- Photo
-
-
J.D., 1999, Harvard Law School
-
B.A., 1996, Columbia UniversityPhi Beta Kappa, summa cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 1987, Fordham University School of Lawcum laude
-
B.A., 1984, University of Pennsylvaniacum laude
Education
Related News & Insights
Deals & Cases
January 08, 2026
Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Deals & Cases
December 24, 2025
Ameren’s $3.2 Billion of Revolving Credit Facilities
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $3.2 billion of revolving credit facilities made available to Ameren Corporation and Union Electric Company (the “Missouri Borrowers”) and Ameren Corporation and Ameren Illinois Company (the “Illinois Borrowers”). Ameren Corporation is an American power company that engages in the rate‑regulated electric generation, transmission and distribution activities; and rate‑regulated natural gas distribution and transmission businesses. The facilities consisted of a $1.9 billion revolving credit facility (Missouri Borrowers) and $1.3 billion revolving credit facility (Illinois Borrowers). The transaction closed on December 10, 2025.
Deals & Cases
November 24, 2025
Thomson Reuters Corporation’s $2 Billion Revolving Credit Facility
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $2 billion revolving credit facility made available to Thomson Reuters Corporation, a leading AI and technology company empowering professionals with trusted content and workflow automation. The transaction closed on November 10, 2025.
Deals & Cases
October 30, 2025
Valero Energy Corporation’s $4 Billion Revolving Credit Facility
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $4 billion revolving credit facility made available to Valero Energy Corporation, a leading multinational manufacturer and marketer of petroleum‑based and low‑carbon liquid transportation fuels and petrochemical products. The transaction closed on October 16, 2025.
